RIT Capital Partners Regulatory News (RCP)

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

26 April 2018

Election of Directors

Following the passing of all resolutions by shareholders at its Annual General Meeting, RIT Capital Partners plc ('RIT') announces the following elections to the Board with immediate effect:

André Perold

André Perold has been elected to the Board as a Non-Executive Director. Mr Perold is a Co-Founder, Managing Partner and Chief Investment Officer of HighVista Strategies, a Boston based investment firm. He is a board member of the Vanguard Group, the global investment company and also serves on the Investment Committee of the Partners Healthcare System.

Mr Perold will sit on the Audit & Risk Committee.

There are no other details that require to be disclosed in respect of the appointment of Mr Perold pursuant to Rule 9.6.13 of the UK Listing Rules.

Jeremy Sillem

Jeremy Sillem has been elected to the Board as a Non-Executive Director. Mr Sillem is Managing Partner and Founder of Spencer House Partners LLP, which provides corporate finance advice to asset and wealth management businesses. From 2000 to 2004 he was Executive Chairman of Bear Stearns International in London, prior to which he had a 28-year career with Lazard in London and New York.

Mr Sillem will sit on the Audit & Risk Committee.

Mr Sillem is currently a director of Biopharma Credit PLC. There are no other details that require to be disclosed in respect of the appointment of Mr Sillem pursuant to Rule 9.6.13 of the UK Listing Rules.

Composition of Board Committee

Phillipe Costeletos has been appointed as a member of the Remuneration Committee of RIT, with immediate effect.